Epigenetics and Systems Biology Lecture Outline – Systems Biology Michael K
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Systems Biomedicine: It’S Your Turn —Recent Progress in Systems Biomedicine
Quantitative Biology QB DOI 10.1007/s40484-013-0009-z REVIEW Systems biomedicine: It’s your turn —Recent progress in systems biomedicine Zhuqin Zhang, Zhiguo Zhao, Bing Liu, Dongguo Li, Dandan Zhang, Houzao Chen and Depei Liu* State Key Laboratory of Medical Molecular Biology, Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China * Correspondence: [email protected] Received December 25, 2012; Revised April 9, 2013; Accepted April 19, 2013 The concept of “systems biology” is raised by Hood in 1999. It means studying all components with a systematic view. Systems biomedicine is the application of systems biology in medicine. It studies all components in a whole system and aims to reveal the patho-physiologic mechanisms of disease. In recent years, with the development of both theory and technology, systems biomedicine has become feasible and popular. In this review, we will talk about applications of some methods of omics in systems biomedicine, including genomics, metabolomics (proteomics, lipidomics, glycomics), and epigenomics. We will particularly talk about microbiomics and omics for common diseases, two fields which are developed rapidly recently. We also give some bioinformatics related methods and databases which are used in the field of systems biomedicine. At last, some examples that illustrate the whole biological system will be given, and development for systems biomedicine in China and the prospect for systems biomedicine will be talked about. INTRODUCTION plus cooperation between different fields, including biology, mathematics and computer science, systems The concept of “systems biology” is raised by Hood in biomedicine has received renewed interest. -
Systems Biology Lecture Outline (Systems Biology) Michael K
Spring 2019 – Epigenetics and Systems Biology Lecture Outline (Systems Biology) Michael K. Skinner – Biol 476/576 CUE 418, 10:35-11:50 am, Tuesdays & Thursdays January 22 & 29, 2019 Weeks 3 and 4 Systems Biology (Components & Technology) Components (DNA, Expression, Cellular, Organ, Physiology, Organism, Differentiation, Development, Phenotype, Evolution) Technology (Genomics, Transcriptomes, Proteomics) (Interaction, Signaling, Metabolism) Omics (Data Processing and Resources) Required Reading ENCODE (2012) ENCODE Explained. Nature 489:52-55. Tavassoly I, Goldfarb J, Iyengar R. (2018) Essays Biochem. 62(4):487-500. Literature Sundaram V, Wang T. Transposable Element Mediated Innovation in Gene Regulatory Landscapes of Cells: Re-Visiting the "Gene-Battery" Model. Bioessays. 2018 40(1). doi: 10.1002/bies.201700155. Abil Z, Ellefson JW, Gollihar JD, Watkins E, Ellington AD. Compartmentalized partnered replication for the directed evolution of genetic parts and circuits. Nat Protoc. 2017 Dec;12(12):2493- 2512. Filipp FV. Crosstalk between epigenetics and metabolism-Yin and Yang of histone demethylases and methyltransferases in cancer. Brief Funct Genomics. 2017 Nov 1;16(6):320-325. Chen Z, Li S, Subramaniam S, Shyy JY, Chien S. Epigenetic Regulation: A New Frontier for Biomedical Engineers. Annu Rev Biomed Eng. 2017 Jun 21;19:195-219. Hollick JB. Paramutation and related phenomena in diverse species. Nat Rev Genet. 2017 Jan;18(1):5-23. Macovei A, Pagano A, Leonetti P, Carbonera D, Balestrazzi A, Araújo SS. Systems biology and genome-wide approaches to unveil the molecular players involved in the pre-germinative metabolism: implications on seed technology traits. Plant Cell Rep. 2017 May;36(5):669-688. Bagchi DN, Iyer VR. -
Course Catalog (Published 5/24/18)
Icahn School of Medicine at Mount Sinai Graduate School of Biomedical Sciences Course Catalog (Published 5/24/18) BIO 1 BMI 6 BSR 13 CLR 36 HCD 44 MGC 50 MPH 52 MSN 83 BIO BIO 6000 Capstone I MS Biostatistics Course Director(s): Bagiella, Emilia The Capstone is a required three-semester course for students in the MS in Biostatistics Program. It provides experience in the art of consulting and in the proper application of statistical techniques to clinical and translational research. Students will bring together the skills they have acquired in previous coursework and apply them to the consulting experience. Learning will take place by doing. In the Fall term, the capstone-related lectures and project will engage students in important discourse regarding data management and research ethics. Prerequisites: Must be enrolled in the MS in Biostatistics program Credits: 1 | Offered: Fall BIO 6100 Fundamentals of Epidemiology Course Director(s): Liu, Bian This course provides a rigorous introduction to epidemiology for students in the first trimester of the MS in Biostatistics program. Topics covered include: an introductory overview of epidemiology, common measures of health outcome frequencies and associations, appropriate construction of an epidemiologic 1 Icahn School of Medicine at Mount Sinai Graduate School of Biomedical Sciences Course Catalog (Published 5/24/18) hypothesis, causal inferences, common epidemiologic study designs, error and bias in epidemiologic studies, confounding and effect modification, critique review and evaluation of published studies, ethics and reproducibility in epidemiologic research. Credits: 3 | Offered: Fall BIO 6300 Introduction to R Programming Course Director(s): Benn, Emma In this course, students will gain a comprehensive, hands-on, introduction to statistical computing for data management and statistical analysis in R, a free, open source, statistical software. -
A Roadmap Towards Personalized Immunology
www.nature.com/npjsba REVIEW ARTICLE OPEN A roadmap towards personalized immunology Sylvie Delhalle1, Sebastian F. N. Bode1,2, Rudi Balling3, Markus Ollert1,4 and Feng Q. He 1 Big data generation and computational processing will enable medicine to evolve from a “one-size-fits-all” approach to precise patient stratification and treatment. Significant achievements using “Omics” data have been made especially in personalized oncology. However, immune cells relative to tumor cells show a much higher degree of complexity in heterogeneity, dynamics, memory-capability, plasticity and “social” interactions. There is still a long way ahead on translating our capability to identify potentially targetable personalized biomarkers into effective personalized therapy in immune-centralized diseases. Here, we discuss the recent advances and successful applications in “Omics” data utilization and network analysis on patients’ samples of clinical trials and studies, as well as the major challenges and strategies towards personalized stratification and treatment for infectious or non-communicable inflammatory diseases such as autoimmune diseases or allergies. We provide a roadmap and highlight experimental, clinical, computational analysis, data management, ethical and regulatory issues to accelerate the implementation of personalized immunology. npj Systems Biology and Applications (2018)4:9; doi:10.1038/s41540-017-0045-9 INTRODUCTION biomarkers.6–11 It is worthy to note that so far one of the most Continuous improvements in laboratory technologies and com- ambitious personalized medicine trials (NCT02465060, known as putational biomedicine have enabled the generation and proces- NCI-MATCH, launched in 2015) is recruiting thousands of sing of vast amounts of data, prerequisites that will allow medicine participants to differentially treat individual patients suffering to evolve from a “one-size-fits-all” approach to a more detailed from solid tumors or lymphomas according to their genetic patient stratification and future personalized treatment.